Dual-phoretic wireless device for directionally oriented and carrier-free targeted drug deliveryopen access
- Authors
- Choi, Sung-Geun; Kim, Seongchan; Kim, Joon-Woo; Choi, Myung-Kyun; Han, Jieun; Koo, Dong-Jun; Lee, Soo-Hwan; Kim, Aejin; Gu, Ji-Woo; Kim, Ki Hun; Lee, Ju-Yong; Bae, Jae-Young; Kim, Sung-Yon; Kim, Jeonghyun; Lee, Hyojin; Kang, Seung-Kyun
- Issue Date
- Jul-2025
- Publisher
- American Association for the Advancement of Science
- Keywords
- Biological Organs; Controlled Drug Delivery; Disease Control; Drug Products; Electrophoresis; Electrotherapeutics; Ions; Biological Barrier; Drug-delivery Systems; Localisation; Localised; Physical Control; Release Control; Solid Tissues; Therapeutic Efficacy; Tight Junctions; Wireless Devices; Targeted Drug Delivery; Animal; Devices; Drug Delivery System; Drug Release; Human; Mouse; Procedures; Tumor Cell Line; Wireless Communication; Animals; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Humans; Mice; Wireless Technology
- Citation
- Science Advances, v.11, no.28
- Indexed
- SCIE
SCOPUS
- Journal Title
- Science Advances
- Volume
- 11
- Number
- 28
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/79491
- DOI
- 10.1126/sciadv.ads9269
- ISSN
- 2375-2548
2375-2548
- Abstract
- Drug localization, release control, and penetration into solid tissues through biological tight junctions are crucial for the treatment of localized diseases with biological barriers by maximizing therapeutic efficacy of the drug and minimizing damage to normal organs. Here, we introduce a dual-phoretic wireless drug delivery system that harnesses the physical control of ion transportation: electrophoresis for controllable release and iontophoresis for directional penetration. Adjustable, pulsatile, and repeatable drug release under biological conditions is achieved using ion diodes and Zn-based electrochemical cells. Through seamless integration with iontophoretic compartments, a fourfold improvement in delivery efficiency compared to drug diffusion, reaching the core of in vivo tumor, is verified by a 3D tomographic analysis. Fully implantable and wireless operation in a simulated 2-week therapeutic scenario results in a remarkable 50% tumor reduction from the initial volume while minimizing damage to nearby normal tissue and off-target organs such as the heart, liver, spleen, and kidney.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 약학대학 > 약학과 > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.